Heterogeneity of B-Lymphoid tumors in Eμ,-myc transgenic mice

Cytometry

Volumn 23, Issue 2, 1996, Pages 131-139

  Prasad, V S ^a   Temple, Matthew J ^b   Davisson, Muriel T ^c   Akeson, Ellen C ^c   Sidman, Charles L ^a,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NAZARETH COLLEGE   (United States)

^c JACKSON LABORATORY   (United States)

^d MSB 3110 ^*  (United States)

Author keywords

c myc oncogene; Chromosomes; Clonality; DNA aneuploidy; Flow cytometry; Igb gene rearrangement; Karyotyping; Scid

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CYTOGENETICS; FLOW CYTOMETRY; GENE REARRANGEMENT; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SCID MOUSE; TRANSGENIC MOUSE;

DROMAIUS NOVAEHOLLANDIAE; MUS MUSCULUS;

EID: 0029983203     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960201)23:2<131::AID-CYTO7>3.0.CO;2-N     Document Type: Article

References (47)

1. Adams JM, Harris AW, Pinkert CA, Corcoran IM, Alexander WS, Corv S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:535-538, 1985.
2. Alexander WS, Schrader JW, Adams JM: Expression of the c-myc oncogene under control of an immunoglobulin enhancer in Eμ-myc transgenic mice Mol Cell Biol 7:1436-1444, 1987
3. Askensten UG, Von Rosen AK, Nilsson RS, Auer GU Intratumoral variations in DNA distribution patterns in mammary adenocarcinomas Cytometry 10:326-333. 1989
4. August DA, Flynn SD, Jones MA, Bagwell CB, Kinder BK. Parathyroid carcinoma. the relationship of nuclear DNA content to clinical outcome. Surgery 113:290-296, 1993
5. Bagwell CB Theoretical aspects of flow cytometry data analysis. In Clinical Flow Cytometry. Principles and Applications, Bauer KD. Shankey TV (eds). Williams and Wilkins, Baltimore, 1993, P. 533
6. Beerman H, Smit VT, Kluin PM, Bonsing BA, Hermans J, Cornelisse CJ: Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer Cytometry 12:147-154, 1991.
7. Bosma GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature (Lond.) 301.527-530, 1983
8. Corcoran LM, Cory S, Adams JM: Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma Cell 40:71-79, 1985
9. Cory S, Gerondakis S, Corcoran LM, Bernard O, Webb E, Adams JM: Activation of the c-myc oncogene in B and T lymphoid tumors. Curr Top Microbiol Immunol 113:161-165, 1984
10. Custer RP, Bosma GC, Bosma MJ: Severe combined immunodeficiency (SCID) in the mouse Pathology, reconstitution, neoplasms Am J Pathol 120:464-477. 1985.
11. Davisson MT, Akeson EC: An inproved method for preparing G-banded chromosomes from muring peripheral blood. Cytogenet Cell Genet 4570-74, 1987.
12. H1 genes in human B-lineage leukaemias. Leukemia 5.646-650, 1991
13. DePinho RA, Schreiber AN. Alt FW myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1-46, 1991
14. Erikson J, Ar-Rushdi A, Drwinga HL, Nowell PC, Croce CM- Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc Natl Acad Sci USA 80:820-824, 1983.
15. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983.
16. Fuhr JE, Frye A, Kattine AA, Van MS. Flow cytometric determination of breast tumor heterogeneity. Cancer 67:1401-1405, 1991.
17. Fulop GM, Phillips RA: The scid mutation in mice causes a general defect in DNA repair. Nature 347:479-482, 1990.
18. Gerondakis S, Cory S, Adams JM: Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell 36.973-982, 1984
19. Greene DR, Taylor SR, Wheeler TM, Scardino PT. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report. Cancer Res 51:4084-4089, 1991.
20. Harris AW, Pinkert CA, Crawford M, Langdon WY, Brinster RL, Adams JM; The Eμ-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med 167. 353-371, 1988.
21. Hiddemann W, Roessner A, Wormann B, Mellin W, Klockenkemper B, Bosing T, Buchner T, Grundmann E: Tumor heterogeneity in osteosarcoma as identified by flow cytometry. Cancer 59:324-328, 1987.
22. Hiddemann W, Schumann J, Andreef M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry Cancer Genet Cytogenet 13:181-183, 1984.
23. Isobe H, Miyamoto H, Inoue K, Shimizu M, Endo T, Mizuno S, Kawakami Y: Flow cytometric DNA content analysis in primary lung cancer: comparison of results from fresh and paraffin-embedded specimens. J Surg Oncol 43:36-39, 1990.
24. Jelinek DF, Ahmann GJ, Greipp PR, Jalal SM, Westendorf JJ, Katzmann JA, Kyle RA, Lust JA: Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer Res 53.5320-5327, 1993
25. Koss LG, Wersto RP, Simmons DA, Deitch D, Herz F, Freed SZ. Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry. and cytology in patients with a past history of urothelial tumors. Cancer 64.916-924, 1989
26. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188-193, 1975.
27. Langdon WY, Harris AW, Cory S, Adams JM: The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice. Cell 47:11-18, 1986.
28. Ljungberg B. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis Scand J Urol Nephrol (Suppl) 100.1-47, 1986.
29. Malynn BA, Blackwell TK, Fulop GM, Rathbun GA, Furley AJ, Ferner P, Heinke LB, Phillips RA, Yancopoulos GD, Alt FW The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54:453-460, 1988.
30. Marcu KB, Banerji J, Penncavage NA, Lang R, Arnheim N: 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell 22:187-196, 1980.
31. Meyer JS, Wittliff JL: Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy. Int J Cancer 47:213-220, 1991.
32. Nau MM, Carney DN, Battey J, Johnson B, Little C, Gazdar A, Minna JD Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer. Curr Top Microbiol Immunol 113:172-177, 1984.
33. Norming U, Nyman CR, Tribukait B: Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder. J Urol 142: 1442-1447, 1989.
34. Reed KC, Mann DA: Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res 13:7207-7221, 1985.
35. Schatz DG, Oettinger MA, Schlissel MS: V(D)J recombination: molecular biology and regulation. Annu Rev Immunol 10:359-383, 1992.
36. Schuler W, Weiler IJ, Schuler A, Phillips RA, Rosenberg N, Mak TW, Kearney JF, Perry RP, Bosma MJ. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46:963-972, 1986.
37. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE. Hedley DW, Mayall BH, Wheeless L: Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 14:472-477, 1993.
38. Sidman CL, Denial TM, Marshall JD, Roths JB: Multiple mechanisms of tumongenesis in Eμ-myc transgenic mice. Cancer Res 53:1665-1669, 1993.
39. Sidman CL, Marshall JD, Harris AW: Genetic studies on Eμ-myc transgenic mice Curr Top Microbiol Immunol 141.94-99, 1988.
40. Sidman CL, Shaffcr DJ, Jacobsen K, Vargas SR, Osmond DJ Cell populations during tumorigenesis in Eμ-myc transgenic mice. Leukemia 7:887-895, 1993.
41. Solomon E, Borrow J, Goddard AD: Chromosome aberrations and cancer. Science 254 1153-1160, 1991.
42. Taylor BA. Rowe L: Genes for serum amyloid A proteins map to chromosome 7 in the mouse. Mol Gen Genet 195:491-499. 1984
43. Taylor JJ, Rowe D, Williamson LK, Christmas SE, Proctor SJ, Middleton PG: Detection of T-cell receptor g chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia. Blood 77: 1989-1995, 1991.
44. Tonegawa S: Somatic generation of antibody diversity Nature 302. 575-581, 1983.
45. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 65:737-752, 1991
46. Vaux DL, Adams JM, Alexander WS, Pike BL Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice J Immunol 139:3854-3860, 1987.
47. Wersto RP, Liblit RL, Deitch D, Koss LG: Variability in DNA measurements in multiple tumor samples of human colonic carcinoma. Cancer 67.106-115 1991.